Who are Application of T-lymphocytes's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Bacillus Calmette-Guerin (BCG), BCG Solution, Pf-06835375, Allergovit Birch pollen, HAART + Immunotherapy, Novel dose adjustment of Alutard SQ.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/application-of-t-lymphocytes.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Application of T-lymphocytes — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Application of T-lymphocytes (Application of T-lymphocytes) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunotherapy. Area: Immunology.

phase 2 Immunotherapy T-lymphocytes Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Application of T-lymphocytes (Application of T-lymphocytes) — Hannover Medical School. Application of T-lymphocytes targets the immune system

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Application of T-lymphocytes TARGET	Application of T-lymphocytes	Hannover Medical School	phase 2	Immunotherapy	T-lymphocytes
Bacillus Calmette-Guerin (BCG)	Bacillus Calmette-Guerin (BCG)	Massachusetts General Hospital	marketed	Live attenuated vaccine / Immunotherapy
BCG Solution	BCG Solution	Alliance for Clinical Trials in Oncology	marketed	Live attenuated vaccine / Immunotherapy
Pf-06835375	pf-06835375	Pfizer	marketed	Immunotherapy	PD-L1
Allergovit Birch pollen	Allergovit Birch pollen	Royal Sussex County Hospital	marketed	Allergen immunotherapy
HAART + Immunotherapy	HAART + Immunotherapy	Juan A. Arnaiz	marketed	Combination antiretroviral + immunotherapy
Novel dose adjustment of Alutard SQ	Novel dose adjustment of Alutard SQ	Beijing Tongren Hospital	marketed	Allergen immunotherapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunotherapy class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Beijing Tiantan Hospital · 1 drug in this class
CytoVac A/S · 1 drug in this class
Hannover Medical School · 1 drug in this class
Pfizer · 1 drug in this class
The Cleveland Clinic · 1 drug in this class
Zarour, Hassane, MD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Application of T-lymphocytes — Competitive Intelligence Brief. https://druglandscape.com/ci/application-of-t-lymphocytes. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab